M.D., Chief Medical Officer of Werew - Interim phase 1 clinical trial update reveals the clinical potential of the tumor-activated IL-12 prodrug WTX-330, with favorable tolerability profile and ...

Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...

Until now, it was unclear how they entered cells at all. In this study, the PROTAC drugs tested were over 1,000 Da, which is enormous by pharmaceutical standards. But the modified PROTACs not only ...

At close: April 9 at 4:00:00 p.m. EDT ...